Table 1.
Baseline characteristics of patients in the Cingal 13-01 trial by treatment arm.
| Characteristic | Cingal (n = 149) | Monovisc (n = 150) | Saline (n = 69) |
|---|---|---|---|
| Age, y (mean ± SD) | 57.52 ± 8.39 | 59.19 ± 8.62 | 58.03 ± 9.02 |
| Female, No. (%) | 97 (65.10) | 99 (66.00) | 51 (73.91) |
| Body mass index, kg/m2 (mean ± SD) | 28.9 ± 4.7 | 28.4 ± 4.5 | 29.1 ± 4.5 |
| Kellgren-Lawrence grade, No. (%) | |||
| I | 36 (24.2) | 24 (16.0) | 17 (24.6) |
| II | 84 (56.4) | 98 (65.3) | 38 (55.1) |
| III | 29 (19.4) | 27 (18.0) | 14 (20.3) |
| IV | 0 (0.0) | 1 (0.7) | 0 (0.0) |
| WOMAC pain, mm (mean ± SD) | 59.0 ± 12.4 | 61.0 ± 11.7 | 58.8 ± 10.6 |
| WOMAC stiffness, mm (mean ± SD) | 53.6 ± 19.3 | 57.2 ± 17.1 | 54.2 ± 17.9 |
| WOMAC function, mm (mean ± SD) | 55.0 ± 16.2 | 56.8 ± 16.8 | 55.8 ± 15.7 |
Abbreviation: WOMAC, Western Ontario and McMaster Universities Arthritis Index.